CLA-2-29:OT:RR:NC:N3:138
Ms. Sheila Heerdt
Ren Pharm International Ltd.
350 Jericho Turnpike, Suite 204
Jericho, NY 11753
RE: The tariff classification of Prednisolone Acetate (CAS No. 52-21-1) in bulk powder form, from Italy
Dear Ms. Heerdt:
In your letter dated May 30, 2019, you requested a tariff classification ruling.
Prednisolone Acetate is the 21-acetate ester of prednisolone, a synthetic adrenocortical hormone (corticosteroid). Prednisolone Acetate is indicated for the treatment of allergic conjunctivitis, acne rosacea, superficial punctate keratitis, herpes zoster keratitis and iritis.
The applicable subheading for the Prednisolone Acetate in bulk powder form will be 2937.29.9040, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Steroidal hormones, their derivatives and structural analogues: Other: Other: Salts and esters of Prednisolone.” The rate of duty will be free.
Duty rates are provided for your convenience and are subject to change. The text of the most recent HTSUS and the accompanying duty rates are provided on the World Wide Web at https://hts.usitc.gov/current.
This merchandise may be subject to the Federal Food, Drug, and Cosmetic Act and/or The Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (The Bioterrorism Act), which are administered by the U.S. Food and Drug Administration (FDA). Information on the Federal Food, Drug, and Cosmetic Act, as well as The Bioterrorism Act, can be obtained by calling the FDA at 1-888-463-6332, or by visiting their website at www.fda.gov.
This ruling is being issued under the provisions of Part 177 of the Customs Regulations (19 C.F.R. 177).
A copy of the ruling or the control number indicated above should be provided with the entry documents filed at the time this merchandise is imported. If you have any questions regarding the ruling, contact National Import Specialist Judy Lee at [email protected].
Sincerely,
Steven A. Mack
Director
National Commodity Specialist Division